Previously, it has been shown that BRAF mutant colon cancer cell lines have higher levels of phospho-protein kinase B (AKT) indicative of an activation of the phosphoinositide 3-kinase (PI3K)–AKT pathway when compared to BRAF mutant melanoma [1]. This evidence concerns the gene BRAF and melanoma.